Cargando…

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma

BACKGROUND: Metastatic colorectal cancer (mCRC) patients with mutant KRAS or NRAS are ineligible for anti-epidermal growth factor receptor (anti-EGFR) therapy, as RAS mutations activate downstream pathways independently of EGFR and induce primary resistance. However, even among RAS wild-type (WT) pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lièvre, Astrid, Ouine, Bérèngere, Canet, Jim, Cartier, Aurélie, Amar, Yael, Cacheux, Wulfran, Mariani, Odette, Guimbaud, Rosine, Selves, Janick, Lecomte, Thierry, Guyetant, Serge, Bieche, Ivan, Berger, Frédérique, de Koning, Leanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729470/ https://www.ncbi.nlm.nih.gov/pubmed/29024937 http://dx.doi.org/10.1038/bjc.2017.353

Ejemplares similares

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
por: Lièvre, Astrid, et al.
Publicado: (2018)

Arpin downregulation in breast cancer is associated with poor prognosis
por: Lomakina, Maria E, et al.
Publicado: (2016)

Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
por: Cacheux, Wulfran, et al.
Publicado: (2016)

Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies
por: Byron, Adam, et al.
Publicado: (2020)

Exploring the basis of heterogeneity of cancer aggressiveness among the mutated POLE variants
por: Selves, Janick, et al.
Publicado: (2023)

Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition
por: El Botty, Rania, et al.
Publicado: (2018)

KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
por: Bournet, Barbara, et al.
Publicado: (2016)

Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy
por: Serayssol, Chloé, et al.
Publicado: (2019)

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy
por: Gauthé, Mathieu, et al.
Publicado: (2018)

The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity
por: Labrousse, Guillaume, et al.
Publicado: (2023)

Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer
por: Meseure, Didier, et al.
Publicado: (2016)

Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences
por: Cacheux, Wulfran, et al.
Publicado: (2018)

Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma
por: Cacheux, Wulfran, et al.
Publicado: (2017)

ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels
por: Rondeau, S, et al.
Publicado: (2015)

Sporadic Early-Onset Colorectal Cancer Is a Specific Sub-Type of Cancer: A Morphological, Molecular and Genetics Study
por: Kirzin, Sylvain, et al.
Publicado: (2014)

The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients
por: Mavridis, K, et al.
Publicado: (2015)

Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR
por: Gao, Jie, et al.
Publicado: (2016)

Localisation of renin-angiotensin system (RAS) components in breast
por: Tahmasebi, M, et al.
Publicado: (2006)

Impact of chromosomal instability on colorectal cancer progression and outcome
por: Orsetti, Béatrice, et al.
Publicado: (2014)

PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma
por: de Koning, Leanne, et al.
Publicado: (2019)

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
por: Kalikaki, A, et al.
Publicado: (2008)

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
por: Schirripa, M, et al.
Publicado: (2015)

Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma
por: Lièvre, A, et al.
Publicado: (2006)

Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma
por: Tsantoulis, Petros, et al.
Publicado: (2019)

K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene
por: Hachisuga, T, et al.
Publicado: (2005)

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
por: Mascaux, C, et al.
Publicado: (2005)

Mechanistic Signatures of Human Papillomavirus Insertions in Anal Squamous Cell Carcinomas
por: Morel, Adeline, et al.
Publicado: (2019)

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
por: Zuidervaart, W, et al.
Publicado: (2005)

EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
por: Paliga, A, et al.
Publicado: (2012)

Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping
por: Beau-Faller, M, et al.
Publicado: (2009)

Prospective comparative study of quantitative X-ray (QXR) versus dual energy X-ray absorptiometry to determine the performance of QXR as a predictor of bone health for adult patients in secondary care
por: Rangan, Amar, et al.
Publicado: (2021)

Hedgehog pathway activation in human transitional cell carcinoma of the bladder
por: Pignot, G, et al.
Publicado: (2012)

An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes
por: Jaffrelot, Marion, et al.
Publicado: (2021)

Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers
por: Harlé, A, et al.
Publicado: (2015)

Prognostic Value of Fusobacterium nucleatum after Abdominoperineal Resection for Anal Squamous Cell Carcinoma
por: Hilmi, Marc, et al.
Publicado: (2022)

MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics
por: Di Benedetto, Melanie, et al.
Publicado: (2015)

Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study
por: Samuels, Sanne, et al.
Publicado: (2016)

A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation
por: Weiswald, L-B, et al.
Publicado: (2013)

Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer
por: Solassol, J, et al.
Publicado: (2010)

Splenic Laceration and Pulmonary Contusion Injury From Bean Bag Weapon
por: Patel, Amar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lqh7qd8s7fq1jsj2jbt6netudk